The EU-CARDIOPROTECTION COST Action (CA16225) is a pan-European research network of leading experts in experimental and clinical cardioprotection, whose overall aim is to improve the translation of novel experimental cardioprotective therapies into the clinical setting for patient benefit.
[IJMS] Special Issue “Novel Molecular Targets for Cardioprotection 2020: The EU-CARDIOPROTECTION COST Action (CA16225)May 11, 2020 | General
In this Special Issue “Novel Molecular Targets for Cardioprotection 2020: The EU-CARDIOPROTECTION COST Action (CA16225)” of IJMS, we invite you to submit both review and original preclinical articles on the topic of cardioprotection, with a special focus on novel molecular targets for cardioprotection. Deadline for submission is Dec 31 2020.
6th EU-CARDIOPROTECTION COST Action – WG MeetingNovember 22, 2019 | General
Our 6th COST EU-CARDIOPROTECTION CA16225 Meeting in Riga, Latvia (local organisor Prof Maija Dambrova, Laboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis) was cancelled due to COVID-19, and we have rescheduled it for Oct 7-9 2020. The focus will be on mitochondria and metabolism as targets for cardioprotection. On the first day we […]
5th EU-CARIDOPROTECTION COST Action CA16225 meeting was held in Oslo Sept 16-18 2019September 24, 2019 | General
Our 5th EU-CARIDOPROTECTION COST Action CA16225 meeting was held in Oslo Sept 16-18 2019 with nearly 90 attendees in total. We had a very successful and enjoyable meeting both scientifically and socially. On the first day we held a workshop on animal models used to investigate cardioprotection with a focus on co-morbidities and co-medications which […]
5th EU-CARDIOPROTECTION COST Action MC and WG Meeting, September 16-18, 2019 in OsloJune 28, 2019 | General
Welcome to the 5th EU-CARDIOPROTECTION COST Action MC and WG Meeting, September 16-18th, 2019 in Oslo, Norway at Oslo University Hospital Rikshospitalet! The first day of the meeting is a workshop on animal models and co-morbidities, which is an exciting topic for every researcher in targeting cardiac ischemia/reperfusion injury and will give valuable insights when choosing […]